VESTECK, INC

Carlsbad, CA · Founded 2019 · Medtech · Private

Endosuture Aneurysm Repair (ESAR) platform for minimally invasive aneurysm treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · vesteck.com

Sector: Medtech
Headquarters: Carlsbad, CA
Founded: 2019
Latest Form D: $354K, Oct 2025
Total capital: $8.4M

Federal grants: $1.4M; 1 award · 2025; Rank in peer group#52 of 477
Private capital raised: $7M; 3 Form D · last Oct 2025; 12 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 6 pending · first 2023; Rank in peer group#118 of 477

Capital timeline

Latest events

Oct 2025Private capital raisedForm D · SEC · 3rd filing$354K
Sep 2025Federal grantHealth and Human S · Phase II · Endovascular Suturing Device for Augmentation of Endograft Fixation During Endovascular Repair of Abdominal Aortic Aneurysm to Reduce Reinterventions Due to Endograft Migration or Type 1a Endoleak$1.4M
Jan 2023Private capital raisedForm D · SEC · 2nd filing$2.3M
Sep 2021Private capital raisedForm D · SEC · 1st filing$4.4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

Federal grants#52 · top 11%
Granted patents#118 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

JOHN W. EDOGAResearcherDirectorLinked by 2 patents
Kent StalkerResearcherExecutive OfficerLinked by $1.4M in grants as PI
Benjamin PatzDirectorNamed in SEC Form D filings
Edward WulfmanExecutive OfficerNamed in SEC Form D filings
JOHN W. DIEDERICHDirectorNamed in SEC Form D filings
John DiedrichDirectorNamed in SEC Form D filings

Show all 13 people

JOSEPH W. RAFFERTYExecutive Officer, Director, PromoterNamed in SEC Form D filings
KEN W. RUBENSTEINDirectorNamed in SEC Form D filings
Rafferty JosephExecutive Officer, DirectorNamed in SEC Form D filings
ROBERT W. MITCHELLDirectorNamed in SEC Form D filings
SAIM MERT OZYUREKDirectorNamed in SEC Form D filings
Stephen O'HaraDirectorNamed in SEC Form D filings
THIERRY W. RICHARDDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 8

Dec 11, 2025PendingSutures And Delivery Elements Of Remote Surgical Suture Systems And Devices, And Methods ThereofUSPTOApplication 19017031
Nov 28, 2024PendingRemote Surgical Suture SystemUSPTOApplication 18582544
Mar 26, 2024GrantedRemote Surgical Suture SystemUSPTOUS 11,937,810

Show all 8 patent records

Sutures And Delivery Elements Of Remote Surgical Suture Systems And Devices, And Methods ThereofDec 11, 2025 · Application 19017031Pending
Remote Surgical Suture SystemNov 28, 2024 · Application 18582544Pending
Remote Surgical Suture SystemMar 26, 2024 · US 11,937,810Granted
Remote Surgical Suture SystemAug 8, 2023 · US 11,717,288Granted
Remote Surgical Suture SystemApplication 62706682Pending
Sutures And Delivery Elements Of Remote Surgical Suture Systems And Devices, And Methods ThereofApplication PCTUS2023070175Pending
Sutures And Delivery Elements Of Remote Surgical Suture Systems And Devices, And Methods ThereofApplication 63389157Pending
Remote Surgical Suture SystemApplication PCTUS2021048888Pending

IRX REMINDER, LLCSimilar federal contract value in Medtech · null in contracts
NANOCYTOMICS LLCSimilar federal contract value in Medtech · null in contracts
NEUROGAMI MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
MOONLIGHT THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
ARADIGM CORPORATIONSimilar federal contract value in Medtech · null in contracts
GLOBAL TACTILE, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.